At this year’s Computex, Asus rolled out the VivoWatch 6 Plus, its newest titanium‑cased smartwatch. The device sports a 1.43‑inch AMOLED screen shielded by sapphire crystal glass, giving it a premium feel uncommon in the mid‑range segment. Aside from the visual details, Asus provided few performance numbers and left analysts waiting for battery life or sensor accuracy data.

Both the round and a rectangular variant appeared in the launch images, though the company confirmed only the circular model as the VivoWatch 6 Plus. The titanium frame promises durability, while sapphire glass protects the display from scratches. Asus markets the watch as a daily companion, but pricing and release dates remain undisclosed.

The watch adds on‑wrist blood‑pressure monitoring and ECG capability, joining a growing list of wearables that claim medical‑grade diagnostics. It also tracks sleep‑breathing patterns, movement and gait, data Asus says can highlight chronic‑disease risk and offer actionable guidance. No validation studies or accuracy metrics were included in the brief press release for consumers seeking clinical insight.

By bundling ECG and blood‑pressure sensors, Asus aims to compete with Apple Watch’s health suite and Garmin’s fitness focus. Industry watchers will compare pricing, software ecosystem and third‑party app support to determine if the VivoWatch 6 Plus can attract health‑conscious buyers. Until full specifications arrive, the device remains a design statement rather than a proven health tool.